AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 98 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.12 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $271,000 | -17.9% | 402,118 | 0.0% | 0.07% | -18.9% |
| Q1 2019 | $330,000 | -48.7% | 402,118 | 0.0% | 0.09% | -49.2% |
| Q4 2018 | $643,000 | -51.7% | 402,118 | 0.0% | 0.18% | -26.9% |
| Q3 2018 | $1,331,000 | +46.4% | 402,118 | 0.0% | 0.24% | +10.5% |
| Q2 2018 | $909,000 | -67.5% | 402,118 | -58.3% | 0.22% | -85.5% |
| Q1 2018 | $2,797,000 | +3.9% | 964,520 | 0.0% | 1.51% | +19.9% |
| Q4 2017 | $2,691,000 | -68.5% | 964,520 | -58.8% | 1.26% | -68.2% |
| Q3 2017 | $8,543,000 | +24.5% | 2,340,673 | -24.3% | 3.96% | -17.7% |
| Q2 2017 | $6,861,000 | +184.3% | 3,090,673 | -24.4% | 4.82% | +289.9% |
| Q1 2017 | $2,413,000 | +72.5% | 4,090,673 | +57.9% | 1.24% | +23.4% |
| Q4 2016 | $1,399,000 | -39.3% | 2,590,673 | 0.0% | 1.00% | -39.6% |
| Q3 2016 | $2,306,000 | -7.4% | 2,590,673 | 0.0% | 1.66% | -22.5% |
| Q2 2016 | $2,490,000 | – | 2,590,673 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,590,673 | $1,399,000 | 1.00% |
| Deer VI & Co. LLC | 675,242 | $365,000 | 0.28% |
| Sarissa Capital Management LP | 1,700,000 | $917,000 | 0.25% |
| NEA Management Company, LLC | 10,362,694 | $5,596,000 | 0.22% |
| Perceptive Advisors | 3,108,808 | $1,678,000 | 0.12% |
| Cormorant Asset Management, LP | 1,087,715 | $587,000 | 0.08% |
| 683 Capital Management, LLC | 1,000,000 | $540,000 | 0.04% |
| Spark Investment Management LLC | 95,800 | $51,000 | 0.00% |
| Elgethun Capital Management | 10,000 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 14,738 | $8,000 | 0.00% |